icon_mail.png icon_bookmark.png icon_print.png
Email Bookmark Print

Top Stories

Meet the FIT Team...

UK_index_nurses.png

FIT Recommendations

uk_index_download.png

Discover FIT Techniques Plus

uk_index_expanded.png

FIT Academy

We will shortly be introducing the FIT Academy where you can gain a deeper understanding of the FIT Recommendations.

Click here to request more information.

Search the Site

The Forum for Injection Technique (FIT)
was developed to establish and promote best practice in injection technique for all involved in diabetes care and the founding members are experienced diabetes specialist nurses.

The key aims are to raise awareness of existing andemerging research relating to injection technique and the impact this may have on health outcomes for those with diabetes that require subcutaneous injection therapy. 

FIT was established following the publication of the international New injection recommendations for patients with diabetes, (Diabetes & Metabolism 2010). These are the first Irish recommendations for Injection Technique. These recommendations are adapted from the First UK FIT Injection Technique Recommendations 2nd Edition 2010. 

Diabetes is a major chronic illness, with type 2 diabetes affecting 1 in 20 people in Irelandi. It is estimated that 180,000 people, of all age groups, in Ireland have either type 1 or type 2 diabetes, and this is expected to rise to 233,000 by 2020ii. Recent  research conducted by Diabetes Ireland shows that one in three people has a family member with diabetesiii.

The cost of diabetes care is becoming an increasing burden for the Irish Health  Service Executive. Diabetes treatment and complications make up to 5% of Irish  national health expenditure.iv

It is estimated that almost 30% of people with diabetes use injectable therapiesv,  which, based on current figures, can be calculated as approximately 54,000 Irish  people. For injectable therapies to work optimally, correct injection technique is  essential and, therefore, an improvement in technique could potentially contribute to  managing the cost of diabetes care.

FIT is an autonomous organisation whose mission is to support people with diabetes  requiring injectable therapies in achieving the best possible health outcomes, by ensuring that the correct dose is delivered to the correct injection site, using the  correct technique, each and every time.

The development of FIT and the subsequent Irish recommendations for injection  technique have been supported by BD Europe and endorsed by various bodies in Ireland including pharmaceutical companies whose therapies include subcutaneous  injections of insulin and GLP-1 agonists.

FIT is committed to supporting the implementation of the recommendations by all  those involved in diabetes care. These recommendations will be updated at regular  intervals to include new research evidence as it emerges. We therefore welcome any comments, suggestions and active participation in ensuring that the recommendations remain relevant and useful for now and the future.

Helen Twamley
Clinical Nurse Manager 2 Chair

Sonya Browne
Clinical Nurse Specialist

Helen Burke
Advanced Nurse Practitioner

Patricia Coady
Clinical Nurse Specialist

Yvonne Moloney
Clinical Midwife Specialist

DATE PUBLISHED: OCTOBER 2012
iHealth Service Executive, Review of Diabetes Structured Education, Republic of Ireland 2009
http://www.hse.ie/eng/services/Publications/topics/Diabetes/diabetesstructureded.pdf
iiSource: Irish Times, Diabetes at crisis level in Ireland, new figures confirm (October 4th 2011)
http://www.irishtimes.com/newspaper/health/2011/1004/1224305196665.html
iiiSource: Diabetes Federation of Ireland, One in three families affected by diabeteshttp://www.diabetes.ie/2011/10/03/know-your-numbers/
ivHealth Service Executive, Review of Diabetes Sructured Education, Republic of Ireland 2009
vDiabetes inhaler rejected for NHS, BBC News, 19 April 2006